Literature DB >> 3820537

Twenty year autopsy statistics of myocarditis incidence in Japan.

S Wakafuji, R Okada.   

Abstract

In the annuals of autopsy records in Japan, edited by the Japanese Society of Pathology and covering 20 years, from 1958 to 1977, 377841 autopsy cases are registered with a short summary of the pathology findings. Of these, 434 cases with idiopathic, interstitial, viral, non-specific (NSM) and giant cell (GCM) myocarditis were found. The incidences of NSM and GCM were 0.11 and 0.007%, respectively. The annual incidence of NSM showed periodic fluctuations with in 5-year intervals and increased remarkably after 1974. Incidence of GCM showed a similar fluctuation but with a one to two year delay of peaks. The male to female ratio was 1.2: 1 and the age distribution had two peaked patterns for both sexes, though these peaks were scattered widely from neonate to elderly patients. The regional distribution of NSM showed a concentration in the middle portion of Honshu and its regional annual incidence had propagation waves from the central area to peripheral areas. The same tendency was observed in GCM cases. Hokkaido was characterized by a low incidence of NSM and no GCM. Complications of myocarditis included pancreatitis, pneumonitis, interstitial nephritis, meningoencephalitis, hepatitis, hepatic cirrhosis and a considerable incidence of malignancies. Antibiotics, antineoplastic agents, steroids and irradiation therapy were the main forms of treatment applied before or after the start of myocarditis.

Entities:  

Mesh:

Year:  1986        PMID: 3820537     DOI: 10.1253/jcj.50.1288

Source DB:  PubMed          Journal:  Jpn Circ J        ISSN: 0047-1828


  9 in total

1.  Giant cell myocarditis.

Authors:  Naga Vaishnavi Gadela; Anand Muthu Krishnan; Osama Mukarram; Nitya Sthalekar
Journal:  Proc (Bayl Univ Med Cent)       Date:  2021-01-22

2.  Sudden cardiac death due to ventricular fibrillation in a case of giant cell myocarditis.

Authors:  Tomohiko C Umei; Yuya Murata; Yukihiko Momiyama
Journal:  J Cardiol Cases       Date:  2020-03-12

3.  In vivo ablation of type I interferon receptor from cardiomyocytes delays coxsackieviral clearance and accelerates myocardial disease.

Authors:  Nadine Althof; Stephanie Harkins; Christopher C Kemball; Claudia T Flynn; Mehrdad Alirezaei; J Lindsay Whitton
Journal:  J Virol       Date:  2014-02-26       Impact factor: 5.103

4.  Thymoma associated with fatal myocarditis and polymyositis in a 58-year-old man following treatment with carboplatin and paclitaxel: A case report.

Authors:  Hidefumi Sasaki; Motoki Yano; Osamu Kawano; Yu Hikosaka; Yoshitaka Fujii
Journal:  Oncol Lett       Date:  2011-11-30       Impact factor: 2.967

Review 5.  Myocarditis.

Authors:  Lori A Blauwet; Leslie T Cooper
Journal:  Prog Cardiovasc Dis       Date:  2010 Jan-Feb       Impact factor: 8.194

Review 6.  Epidemiological Impact of Myocarditis.

Authors:  Ainoosh Golpour; Dimitri Patriki; Paul J Hanson; Bruce McManus; Bettina Heidecker
Journal:  J Clin Med       Date:  2021-02-05       Impact factor: 4.241

7.  Giant cell myositis and myocarditis revisited.

Authors:  Piraye Oflazer
Journal:  Acta Myol       Date:  2020-12-01

8.  Giant cell myocarditis causing sudden death in a patient with sarcoidosis.

Authors:  John P Ziegler; Nicholas I Batalis; James W Fulcher; Michael E Ward
Journal:  Autops Case Rep       Date:  2020-11-20

Review 9.  Myocarditis following COVID-19 vaccination: incidence, mechanisms, and clinical considerations.

Authors:  John R Power; Lucas K Keyt; Eric D Adler
Journal:  Expert Rev Cardiovasc Ther       Date:  2022-04-18
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.